CANADIAN COST-EFFECTIVENESS ANALYSIS OF DEFERIPRONE COMPARED TO DEFEROXAMINE AND DEFERASIROX FOR THE TREATMENT OF IRON OVERLOAD IN PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

被引：0
|
作者：
Azimpour, K. [1 ]
Ramjee, L. [2 ]
Tremblay, G. [3 ]
Cha, E. [1 ]
机构：
[1] Chiesi, Boston, MA USA
[2] Cytel Inc, Cambridge, MA USA
[3] Cytel Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE148
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF THE COST-EFFECTIVENESS OF IRON FORMULATIONS FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE UK
    Aksan, A.
    Baxter, G.
    Serna, Ramirez de Arellano A.
    Gavata-Steiger, S.
    Valentine, W.
    Hunt, B.
    VALUE IN HEALTH, 2020, 23 : S742 - S742
  • [42] Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK
    Aksan, Aysegul
    Beales, Ian L. P.
    Baxter, Garth
    de Arellano, Antonio Ramirez
    Gavata, Simona
    Valentine, William J.
    Hunt, Barnaby
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 541 - 552
  • [43] Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'
    Munoz, Manuel
    Reinisch, Walter
    ADVANCES IN THERAPY, 2022, 39 (01) : 811 - 814
  • [44] Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
    Manuel Muñoz
    Walter Reinisch
    Advances in Therapy, 2022, 39 : 811 - 814
  • [45] COST-EFFECTIVENESS ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SPAIN
    Arguelles, F.
    Bermejo, F.
    Borras Blasco, J.
    Domenech, E.
    Sicilia, B.
    Huguet, J. M.
    Serna, Ramirez de Arellano A.
    Valentine, W.
    Hunt, B.
    VALUE IN HEALTH, 2022, 25 (01) : S95 - S95
  • [46] Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
    Arguelles-Arias, Federico
    Bermejo, Fernando
    Borras-Blasco, Joaquin
    Domenech, Eugeni
    Sicilia, Beatriz
    Huguet, Jose M.
    de Arellano, Antonio Ramirez
    Valentine, William J.
    Hunt, Barnaby
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [47] Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves' Disease in Ethiopia
    Mengistu, Habtamu Solomon
    Getahun, Kidus Tesfaye
    Alemayehu, Lake
    Gezahign, Sifrash
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 221 - 229
  • [48] COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
    Farkouh, R.
    Wilson, M. R.
    Tarrants, M. L.
    Castelli-Haley, J.
    Armand, C.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [49] Cost-effectiveness of rasagiline compared to other first line treatment options of early Parkinson's disease in the United States
    Farkouh, R.
    Wilson, M.
    Tarrants, M.
    Castelli-Haley, J.
    Armand, C.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S135 - S135
  • [50] Gene Therapy Equity in Sickle Cell Disease: Distributional Cost-Effectiveness Analysis (DCEA) of Gene Therapy Vs. Standard-of-Care in Patients with Sickle Cell Disease in the United States
    Goshua, George
    Calhoun, Cecelia
    Cheng, Vivien
    James, Lyndon
    Luviano, Andrea
    Krishnamurti, Lakshmanan
    Pandya, Ankur
    BLOOD, 2022, 140 : 1395 - 1396
12345